Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,286 | 299 | 98.2% |
| Education | $117.12 | 18 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,052 | 46 | $0 (2024) |
| Novo Nordisk Inc | $702.22 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $604.00 | 36 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $484.37 | 21 | $0 (2023) |
| Amgen Inc. | $471.94 | 21 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $368.32 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $353.77 | 24 | $0 (2023) |
| PFIZER INC. | $306.22 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $232.27 | 13 | $0 (2023) |
| Lilly USA, LLC | $222.72 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.46 | 14 | AstraZeneca Pharmaceuticals LP ($134.65) |
| 2023 | $342.49 | 17 | AstraZeneca Pharmaceuticals LP ($90.10) |
| 2022 | $953.82 | 43 | Novo Nordisk Inc ($242.38) |
| 2021 | $1,306 | 77 | Amgen Inc. ($179.58) |
| 2020 | $760.79 | 49 | Amgen Inc. ($117.67) |
| 2019 | $445.42 | 21 | Amgen Inc. ($96.75) |
| 2018 | $794.38 | 32 | AstraZeneca Pharmaceuticals LP ($249.64) |
| 2017 | $1,392 | 64 | Boehringer Ingelheim Pharmaceuticals, Inc. ($340.75) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $65.03 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardio-renal | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Respiratory | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Respiratory | ||||||
| 01/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $7.88 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.18 | General |
| 08/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardio-renal | ||||||
| 08/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.21 | General |
| 07/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Cardio-renal | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.09 | General |
| 05/25/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,454 | 2,608 | $431,995 | $157,855 |
| 2022 | 20 | 1,603 | 3,001 | $487,610 | $171,932 |
| 2021 | 21 | 1,531 | 3,326 | $568,914 | $197,900 |
| 2020 | 20 | 1,491 | 3,430 | $586,456 | $165,152 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 353 | 923 | $199,368 | $70,325 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 194 | 194 | $51,216 | $24,164 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 440 | $63,360 | $21,656 | 34.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 24 | 177 | $44,250 | $12,807 | 28.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 121 | 124 | $11,780 | $8,889 | 75.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 38 | $9,956 | $4,432 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 133 | 136 | $8,840 | $3,993 | 45.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 21 | 26 | $9,048 | $3,590 | 39.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $3,250 | $2,406 | 74.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 63 | $5,292 | $1,551 | 29.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 141 | $9,165 | $1,376 | 15.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 22 | $4,400 | $1,166 | 26.5% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 13 | 14 | $2,940 | $488.32 | 16.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 68 | 100 | $2,050 | $332.00 | 16.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 12 | $720.00 | $261.18 | 36.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $1,680 | $189.38 | 11.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 33 | 48 | $984.00 | $148.42 | 15.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 47 | $1,128 | $51.37 | 4.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 39 | $1,638 | $27.57 | 1.7% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 23 | 31 | $930.00 | $0.52 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 409 | 1,226 | $264,816 | $90,353 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 173 | 173 | $45,672 | $21,603 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 282 | $40,608 | $13,300 | 32.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 24 | 205 | $51,250 | $12,041 | 23.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 169 | 172 | $16,340 | $11,759 | 72.0% |
About Dr. G. Michael Lopez, M.D
Dr. G. Michael Lopez, M.D is a Primary Care healthcare provider based in Las Vegas, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003973397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. G. Michael Lopez, M.D has received a total of $6,403 in payments from pharmaceutical and medical device companies, with $408.46 received in 2024. These payments were reported across 317 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,286).
As a Medicare-enrolled provider, Lopez has provided services to 6,079 Medicare beneficiaries, totaling 12,365 services with total Medicare billing of $692,839. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Other Specialties Internal Medicine
- Location Las Vegas, NM
- Active Since 01/03/2007
- Last Updated 03/05/2025
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003973397
Products in Payments
- ENTRESTO (Drug) $423.92
- JARDIANCE (Drug) $419.65
- Aimovig (Biological) $354.79
- XARELTO (Drug) $348.19
- FARXIGA (Drug) $325.47
- ELIQUIS (Drug) $287.34
- BEVESPI AEROSPHERE (Drug) $273.03
- JANUVIA (Drug) $215.50
- Rybelsus (Drug) $201.25
- BREZTRI (Drug) $191.85
- Ozempic (Drug) $182.79
- NUCALA (Biological) $182.72
- XIFAXAN (Drug) $156.63
- VOQUEZNA (Drug) $125.00
- SOLIQUA 100/33 (Biological) $119.51
- TRULICITY (Drug) $114.03
- Amitiza (Drug) $104.11
- Xultophy 100/3.6 (Drug) $100.00
- PREVNAR 13 (Biological) $98.42
- EVENITY (Biological) $96.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Las Vegas
Brenda Primero, Aprn, APRN
Primary Care — Payments: $6,941
Ms. Jennifer Cribb, Nurse Practitioner, NURSE PRACTITIONER
Primary Care — Payments: $5,266
George Gabriel Toldness, Aprn, APRN
Primary Care — Payments: $2,766
Jocybel Itorralba
Primary Care — Payments: $2,566
Mr. Ruel Mariano, Np, NP
Primary Care — Payments: $2,438
Vesna Radivojevic
Primary Care — Payments: $2,187